Genotypic characterization of HIV variants from PBMCs and spermatozoa
© Sutar et al; licensee BioMed Central Ltd. 2014
Published: 27 May 2014
Several studies have shown that detectable levels of HIV are observed in semen in spite of undetectable viral load in blood following antiretroviral therapy (ART). Also, different HIV variants have been detected in blood and semen of the same individual, suggesting that drugs may not be uniformly effective to control the viral load and infectivity in different tissues and secretions, which in turn may affect sexual transmission of HIV. Hence, genotypic characterization of HIV variants in PBMCs and sperm of the same individual may provide information about the association of these variants with sexual transmission of HIV.
Present study describes characterization of translated amino acid sequence of C2 v3 region of env of HIV-1 C in PBMCs and Spermatozoa of 14 and 5 individuals, respectively. The sequences were analysed for presence of N linked glycosylation sites using the program N-Glycosite. Also, Co receptor usage predictions were done using an online tool, Geno2pheno [Co receptor] 1.2.
Significant differences in the number of N linked glycosylation (NLG) sites were observed in PBMCs and spermatozoa of the same individuals as well as samples collected from different individuals.
This study describes presence of compartmentalization between blood and semen which may influence the effect of ART in control of HIV/AIDS and influence sexual transmission of HIV.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.